Upadacitinib with glucocorticoids superior to glucocorticoids alone for giant cell arteritis remission
1. In this randomized trial, upadacitinib dosed at 15mg with a 26-week glucocorticoid taper showed superior efficacy than placebo with ...
Tag: glucocorticoid
Prenatal Systemic Glucocorticoid Exposure and an Increased Risk of Future Mental Disorders
1. In this cohort study of offspring born to mothers at risk for preterm delivery or diagnosed with an autoimmune ...
Crinecerfont decreases glucocorticoid use in adults with congenital adrenal hyperplasia
1. In this randomized controlled trial, twice daily crinecerfont use was associated with reduced daily glucocorticoid use in adults with ...
Crinecerfont facilitates glucocorticoid dose reduction in pediatric congenital adrenal hyperplasia
1. In this randomized controlled trial of pediatric patients with congenital adrenal hyperplasia (CAH), it was found that treatment with ...
Corticosteroids for Immune-Related Adverse Events and Checkpoint Inhibitor Efficacy
1. When comparing corticosteroid peak dose for immunosuppression for anti–PD-1 plus anti–CTLA-4–related adverse events, the HR for OS was 1.66 ...
The 2 Minute Medicine Podcast Episode 29
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
#VisualAbstract: Low-dose glucocorticoids for rheumatoid arthritis do not increase blood pressure
1. In this pooled analysis of randomized controlled trials, low-dose glucocorticoids taken over a two-year period did not increase patient ...
Low-dose glucocorticoids for rheumatoid arthritis do not increase blood pressure
1. In this pooled analysis of randomized controlled trials, low-dose glucocorticoids taken over a two-year period did not increase patient ...
Reliever-triggered inhaled glucocorticoid therapy in among Black and Latinx adults with asthma
1. Provision of an inhaled glucocorticoid and instruction on its use led to a significantly lower rate of severe asthma ...
#VisualAbstract: High-dose glucocorticoids may be detrimental for the management of patients with advanced melanoma expieriencing immune-related adverse events
Click to read the study in Clinical Cancer Research.